International Journal of Thyroidology

Indexed in /covered by CAS, KoreaScience & DOI/Crossref:eISSN 2466-1899   pISSN 2384-3799

Table. 2.

Table. 2.

Clinicopathologic factors of study group according to lymph node status in papillary thyroid cancer

Variables Group I (n=140) Group II (n=27) p value
Age (years) 43.7±11.0 44.5±10.2 0.729
Gender (Male) 26 (18.6%) 8 (29.6%) 0.191
Tumor size (cm) 0.96±0.66 1.13±0.51 0.568
*PTMC 94 (67.19%) 15 (55.6%) 0.247
Multiple cancer 64 (45.7%) 18 (66.7%) 0.046
Bilateral cancer 45 (32.1%) 16 (59.3%) 0.007
Extrathyroidal extension 84 (60.0%) 26 (96.3%) 0.000
High number of metastatic LN (≥2) 85 (60.7%) 18 (66.7%) 0.560
Macrometastasis on LN 66 (47.1%) 19 (70.4%) 0.002
Extranodal extension 4 (2.9%) 6 (22.2%) 0.000
LN ratio 0.38±0.25 0.34±0.30 0.225
High LN ratio (≥0.4) 52 (37.1%) 11 (40.7%) 0.724
High-risk LN disease 71 (50.71%) 20 (74.1%) 0.026
Off–hormone Thyroglobulin 1.33±2.27 6.69±17.05 0.002

*PTMC: papillary thyroid microcarcinoma (tumor size ≤1.0 cm)

Multiple cancer: multiple tumor in unilateral lobe except bilateral tumor

Int J Thyroidol 2020;13:111-7 https://doi.org/10.11106/ijt.2020.13.2.111
© 2020 Int J Thyroidol